Using UALCAN [40], we analyzed the expression of MAD2L2 in pan-cancer, including glioblastoma (GBM), and found that the transcription levels of MAD2L2 were significantly elevated in almost all cancer tissues compared to normal or adjacent tissues. This evidence concerns the gene MAD2L2 and cancer.